Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

Amgen
Biotech
Topics

Advertisement

Advertisement

Amgen

Share

Top Latest Popular

Yesterday

Repatha Linked to 20% Lower Heart Attack Rate Than Ezetimibe in 544,000-Patient Study Medical Daily 17:50 Sat, 07 Nov

Amgen (AMGN) Stock Could Be 34% Below Fair Value Following Raised Guidance Simply Wall St 11:37 Sat, 07 Nov

Friday

Amgen’s Repatha reduces heart attack risk in real-world study Clinical Trials Arena 11:30 Fri, 06 Nov

Advertisement

Advertisement

Missed Out On Amgen's Run? Here's The Bet Holders Made Simply Wall St 05:13 Fri, 06 Nov

Thursday

Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027? The Motley Fool 16:36 Thu, 05 Nov

Repatha® Lowers Risk Of Heart Attacks By 20% Compared With Ezetimibe In A Large Real-World Study Amgen (Press Release) 14:06 Thu, 05 Nov

Wednesday

Amgen Sees Big Sales Growth But Multiple Products Face Threats Scrip Pharma Intelligence 00:30 Wed, 04 Nov

Tuesday

Operating profits surge by 30% at five star K Club resort RTE 12:47 Tue, 03 Nov

Monday

Amgen Just Gave Its Shareholders Great News The Motley Fool 17:33 Mon, 02 Nov

Advertisement

In the last month

Looking For Growth, Income, and Stability? This Stock Could Offer All 3 The Motley Fool 17:22 Sat, 31 Oct

Amgen (AMGN) Stock Could Trade At A Discount To Cash Flow Simply Wall St 04:59 Sat, 31 Oct

Amgen Announces Webcast Of 2026 Third Quarter Financial Results PR Newswire (Press Release) 20:33 Wed, 28 Oct

Amgen Announces 2026 Fourth Quarter Dividend PR Newswire (Press Release) 22:30 Tue, 27 Oct

Amgen To Present New Data Across Rare And Other Serious Autoimmune Diseases At Acr Convergence 2026 PR Newswire (Press Release) 20:02 Tue, 27 Oct

Amgen vs. Novo Nordisk: Which Healthcare Giant's Stock Is a Better Buy in 2026? The Motley Fool 14:54 Tue, 27 Oct

Nord and Amgen Launch Learning Collaborative to Improve Rare Disease Diagnosis and Care PR Newswire (Press Release) 12:31 Tue, 27 Oct

Amgen drug combined with immunotherapy extends survival in lung cancer trial The Hindu 05:06 Tue, 27 Oct

Amgen Appoints David W. Gibbs To Board Of Directors PR Newswire (Press Release) 21:54 Mon, 26 Oct

ESMO26: 'Unprecedented' results from DeLLphi-305 in SCLC pharmaphorum 12:40 Sun, 25 Oct

Amgen says 'breakthrough' drug improves lung cancer survival by 58% The Independent 10:15 Sun, 25 Oct

Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy? The Motley Fool 08:52 Sun, 25 Oct

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy? The Motley Fool 17:37 Sat, 24 Oct

ESMO26: Zai and Ideaya showcase DLL3 drugs in lung cancer pharmaphorum 12:12 Sat, 24 Oct

ESMO26: Boehringer, Zai and Ideaya showcase DLL3 drugs pharmaphorum 12:02 Sat, 24 Oct

Amgen vs. Eli Lilly: Does the GLP-1 Mania Make Lly Stock a Better Buy in 2026? The Motley Fool 23:02 Thu, 22 Oct

Amgen Foundation Tops $75 Million In Hands-On Biotechnology Education, Reaching 100,000 Students A Year Amgen (Press Release) 14:43 Thu, 22 Oct

Amgen, AstraZeneca Detail Phase III Data For Tezspire’s Likely Third Indication Scrip Pharma Intelligence 23:36 Tue, 20 Oct

Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool 23:11 Tue, 20 Oct

2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going) The Motley Fool 22:10 Tue, 20 Oct

Amgen To Present At The European Society Of Medical Oncology Congress 2026 PR Newswire (Press Release) 21:15 Tue, 20 Oct

Property owners at Trump Doonbeg see post Open dividend RTE 15:33 Fri, 16 Oct

New FDA Approvals: Teva’s Degevma™ (denosumab-adet), Emerge’s Yusimry® (adalimumab-aqvh) JD Supra 21:19 Mon, 12 Oct

A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens The Motley Fool 15:52 Fri, 09 Oct

Amgen (AMGN) In Focus As MariTide Buzz Tests Whether The Stock Is Fully Valued Simply Wall St 04:05 Fri, 09 Oct

Advertisement

My Local News

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Industry Sectors Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna